MEDICAL_&_LEGAL_LIMITED - Accounts

Company Registration No. 04944746 (England and Wales)
MEDICAL & LEGAL LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2020
PAGES FOR FILING WITH REGISTRAR
MEDICAL & LEGAL LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
MEDICAL & LEGAL LIMITED
BALANCE SHEET
AS AT
31 OCTOBER 2020
31 October 2020
- 1 -
2020
2019
Notes
£
£
£
£
Fixed assets
Tangible assets
3
4,306
4,008
Current assets
Debtors
4
22,431
108,434
Cash at bank and in hand
477,595
268,669
500,026
377,103
Creditors: amounts falling due within one year
5
(61,091)
(36,054)
Net current assets
438,935
341,049
Total assets less current liabilities
443,241
345,057
Capital and reserves
Called up share capital
103
103
Profit and loss reserves
443,138
344,954
Total equity
443,241
345,057

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 October 2020 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 21 January 2021
Professor Kayvan Shokrollahi
Director
Company Registration No. 04944746
MEDICAL & LEGAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2020
- 2 -
1
Accounting policies
Company information

Medical & Legal Limited is a private company limited by shares incorporated in England and Wales. The registered office is Northgate, 118 North Street, Leeds, West Yorkshire, United Kingdom, LS2 7PN.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:

 

  • Section 7 ‘Statement of Cash Flows’: Presentation of a statement of cash flow and related notes and disclosures;

  • Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instrument Issues’: Interest income/expense and net gains/losses for each category of financial instrument; basis of determining fair values; details of collateral, loan defaults or breaches, details of hedges, hedging fair value changes recognised in profit or loss and in other comprehensive income;

  • Section 26 ‘Share based Payment’: Share-based payment expense charged to profit or loss, reconciliation of opening and closing number and weighted average exercise price of share options, how the fair value of options granted was measured, measurement and carrying amount of liabilities for cash-settled share-based payments, explanation of modifications to arrangements;

  • Section 33 ‘Related Party Disclosures’: Compensation for key management personnel.

 

The financial statements of the company are consolidated in the financial statements of [XXXXX]. These consolidated financial statements are available from its registered office, [XXXXXX].

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost of assets less their residual values over their useful lives on the following bases:

Fixtures, fittings & equipment
25% straight line
MEDICAL & LEGAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2020
1
Accounting policies
(Continued)
- 3 -

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Impairment of fixed assets

Recoverable amount is the higher of fair value less costs to sell and value in use.

 

An impairment loss is recognised immediately in profit or loss.

1.5
Cash at bank and in hand

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

Changes in the fair value of derivatives that are designated and qualify as fair value hedges are recognised in profit or loss immediately, together with any changes in the fair value of the hedged asset or liability that are attributable to the hedged risk.

1.8
Taxation

The tax expense represents the sum of the tax currently payable.

MEDICAL & LEGAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2020
1
Accounting policies
(Continued)
- 4 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.10
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was 1 (2017: 1).

2020
2019
Number
Number
Total
1
1
MEDICAL & LEGAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2020
- 5 -
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 November 2019
10,233
Additions
1,733
At 31 October 2020
11,966
Depreciation and impairment
At 1 November 2019
6,225
Depreciation charged in the year
1,435
At 31 October 2020
7,660
Carrying amount
At 31 October 2020
4,306
At 31 October 2019
4,008
4
Debtors
2020
2019
Amounts falling due within one year:
£
£
Trade debtors
22,431
61,557
Other debtors
-
46,877
22,431
108,434
5
Creditors: amounts falling due within one year
2020
2019
£
£
Trade creditors
26
-
Corporation tax
33,634
24,592
Other taxation and social security
7,564
9,011
Other creditors
19,867
2,451
61,091
36,054
MEDICAL & LEGAL LIMITED
SCHEDULE OF ADMINISTRATIVE EXPENSES
FOR THE YEAR ENDED 31 OCTOBER 2020
2020
2019
£
£
Administrative expenses
Wages and salaries
7,292
-
Medical supplies
-
61
Use of home as office
208
208
Directors' pension costs - defined contribution scheme
7,500
-
Rent
804
2,079
Secretarial services
513
3,784
Computer running costs
1,089
683
Motor running expenses
4,320
4,140
Travel & subsistance
1,514
5,348
Professional subscriptions
834
1,550
Legal and professional fees
1,653
1,366
Accountancy
1,100
1,000
Bank charges
115
73
Insurances (not premises)
1,616
1,616
Printing and stationery
1,987
1,951
Telecommunications
218
-
Entertaining
569
829
Sundry expenses
279
147
Depreciation
1,435
2,341
33,046
27,176
2020-10-312019-11-01false21 January 2021CCH SoftwareCCH Accounts Production 2020.200No description of principal activityKayvan Shokrollahi049447462019-11-012020-10-31049447462020-10-31049447462019-10-3104944746core:OtherPropertyPlantEquipment2020-10-3104944746core:OtherPropertyPlantEquipment2019-10-3104944746core:CurrentFinancialInstrumentscore:WithinOneYear2020-10-3104944746core:CurrentFinancialInstrumentscore:WithinOneYear2019-10-3104944746core:CurrentFinancialInstruments2020-10-3104944746core:CurrentFinancialInstruments2019-10-3104944746core:ShareCapital2020-10-3104944746core:ShareCapital2019-10-3104944746core:RetainedEarningsAccumulatedLosses2020-10-3104944746core:RetainedEarningsAccumulatedLosses2019-10-3104944746bus:Director12019-11-012020-10-3104944746core:FurnitureFittings2019-11-012020-10-31049447462018-11-012019-10-3104944746core:OtherPropertyPlantEquipment2019-10-3104944746core:OtherPropertyPlantEquipment2019-11-012020-10-3104944746core:WithinOneYear2019-10-3104944746bus:PrivateLimitedCompanyLtd2019-11-012020-10-3104944746bus:SmallCompaniesRegimeForAccounts2019-11-012020-10-3104944746bus:FRS1022019-11-012020-10-3104944746bus:AuditExemptWithAccountantsReport2019-11-012020-10-3104944746bus:FullAccounts2019-11-012020-10-31xbrli:purexbrli:sharesiso4217:GBP